atc_code
stringlengths 1
7
| atc_name
stringlengths 3
95
| ddd
float64 0.1
800
⌀ | uom
stringclasses 10
values | adm_r
stringclasses 18
values | note
stringclasses 96
values |
|---|---|---|---|---|---|
J07AH08
|
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
| null | null | null | null |
D04AA
|
Antihistamines for topical use
| null | null | null | null |
M01AE03
|
ketoprofen
| 0.15 |
g
|
O
| null |
C01AA06
|
lanatoside C
| 1 |
mg
|
O
| null |
C10BX08
|
atorvastatin and acetylsalicylic acid
| null | null | null | null |
A10BD22
|
metformin and evogliptin
| null | null | null | null |
S01EB02
|
carbachol
| 0.4 |
ml
| null | null |
A10AE01
|
insulin (human)
| 40 |
U
|
P
| null |
C08D
|
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
| null | null | null | null |
C01DX04
|
benziodarone
| 0.25 |
g
|
O
| null |
H01BA02
|
desmopressin
| 0.4 |
mg
|
O
| null |
V08DA03
|
perflenapent
| null | null | null | null |
D01BA01
|
griseofulvin
| 0.5 |
g
|
O
| null |
G04CA02
|
tamsulosin
| 0.4 |
mg
|
O
| null |
R03CC13
|
clenbuterol
| 40 |
mcg
|
O
| null |
J02AA02
|
hachimycin
| null | null | null | null |
C05BB
|
Sclerosing agents for local injection
| null | null | null | null |
A12AA04
|
calcium carbonate
| 3 |
g
|
O
| null |
N02AJ03
|
dihydrocodeine and other non-opioid analgesics
| null | null | null | null |
G03DB07
|
promegestone
| null | null | null | null |
D05B
|
ANTIPSORIATICS FOR SYSTEMIC USE
| null | null | null | null |
A03AD02
|
drotaverine
| 0.1 |
g
|
P
| null |
B05XA15
|
potassium lactate
| null | null | null | null |
G01BE
|
Sulfonamides and corticosteroids
| null | null | null | null |
M05BC02
|
eptotermin alfa
| null | null | null | null |
A14AA01
|
androstanolone
| null | null | null | null |
V03AX
|
Other therapeutic products
| null | null | null | null |
D08AB
|
Aluminium agents
| null | null | null | null |
S01CA06
|
fludrocortisone and antiinfectives
| null | null | null | null |
V03AE02
|
sevelamer
| 6.4 |
g
|
O
| null |
D01AC20
|
imidazoles/triazoles in combination with corticosteroids
| null | null | null | null |
N06BA14
|
solriamfetol
| null | null | null | null |
A10BH51
|
sitagliptin and simvastatin
| null | null | null | null |
R06AX21
|
tritoqualine
| null | null | null | null |
N06CA
|
Antidepressants in combination with psycholeptics
| null | null | null | null |
R03AK05
|
reproterol and sodium cromoglicate
| null | null | null | null |
N02BG02
|
rimazolium
| 0.9 |
g
|
O
| null |
A02BD08
|
bismuth subcitrate, tetracycline and metronidazole
| null | null | null | null |
C07CA
|
Beta blocking agents, non-selective, and other diuretics
| null | null | null | null |
R01AD12
|
fluticasone furoate
| 0.11 |
mg
|
N
| null |
P02BA01
|
praziquantel
| 3 |
g
|
O
| null |
D03AX14
|
Centella asiatica herba
| null | null | null | null |
V09IX05
|
fluorodopa (18F)
| null | null | null | null |
L04AA37
|
baricitinib
| 4 |
mg
|
O
| null |
A02BX05
|
bismuth subcitrate
| 0.48 |
g
|
O
| null |
R06AX13
|
loratadine
| 10 |
mg
|
O
| null |
J01GB08
|
sisomicin
| 0.24 |
g
|
P
| null |
H03CA
|
Iodine therapy
| 0.33 |
g
|
P
| null |
A02AB10
|
combinations
| null | null | null | null |
M04A
|
ANTIGOUT PREPARATIONS
| null | null | null | null |
R06AA02
|
diphenhydramine
| 0.2 |
g
|
O
|
chloride
|
N01BB02
|
lidocaine
| null | null | null | null |
L04AB03
|
afelimomab
| null | null | null | null |
N02AC52
|
methadone, combinations excl. psycholeptics
| null | null | null | null |
A11AA04
|
multivitamins and trace elements
| null | null | null | null |
J06BB12
|
encephalitis, tick borne immunoglobulin
| null | null | null | null |
A12AA01
|
calcium phosphate
| 2 |
g
|
O
| null |
C01AC01
|
g-strophanthin
| 0.25 |
mg
|
P
| null |
D05
|
ANTIPSORIATICS
| null | null | null | null |
J05AR19
|
emtricitabine, tenofovir alafenamide and rilpivirine
| null | null | null | null |
S01XA13
|
alteplase
| null | null | null | null |
A10AE02
|
insulin (beef)
| 40 |
U
|
P
| null |
C09AA13
|
moexipril
| 15 |
mg
|
O
| null |
J07BM
|
Papillomavirus vaccines
| null | null | null | null |
C07AA02
|
oxprenolol
| 0.16 |
g
|
O
| null |
C02AB
|
Methyldopa
| null | null | null | null |
N05CD05
|
triazolam
| 0.2 |
mg
|
SL
| null |
G03DB06
|
chlormadinone
| null | null | null | null |
J05AE10
|
darunavir
| 1.2 |
g
|
O
| null |
A07EC02
|
mesalazine
| 1.5 |
g
|
O
| null |
L01EF
|
Cyclin-dependent kinase (CDK) inhibitors
| null | null | null | null |
A11CC01
|
ergocalciferol
| null | null | null | null |
J01MA19
|
garenoxacin
| 0.4 |
g
|
O
| null |
A10BD03
|
metformin and rosiglitazone
| null | null | null | null |
C09CA04
|
irbesartan
| 0.15 |
g
|
O
| null |
N02BA04
|
sodium salicylate
| 3 |
g
|
O
| null |
P01AC04
|
teclozan
| null | null | null | null |
N03AX
|
Other antiepileptics
| null | null | null | null |
G03AC09
|
desogestrel
| null | null | null | null |
G03XC03
|
lasofoxifene
| 0.5 |
mg
|
O
| null |
D08AF
|
Nitrofuran derivatives
| null | null | null | null |
B06AX01
|
crizanlizumab
| null | null | null | null |
A03FA01
|
metoclopramide
| 30 |
mg
|
R
| null |
L01DB06
|
idarubicin
| null | null | null | null |
C01EB03
|
indometacin
| null | null | null | null |
N02BB54
|
propyphenazone, combinations excl. psycholeptics
| 3 |
g
|
O
|
Refers to propyphenazone
|
C03BA04
|
chlortalidone
| 25 |
mg
|
O
| null |
J01EB01
|
sulfaisodimidine
| 4 |
g
|
O
| null |
H01CC01
|
ganirelix
| 0.25 |
mg
|
P
| null |
V09FX01
|
technetium (99mTc) pertechnetate
| null | null | null | null |
J01CR
|
Combinations of penicillins, incl. beta-lactamase inhibitors
| null | null | null | null |
J01CF02
|
cloxacillin
| 2 |
g
|
P
| null |
V01A
|
ALLERGENS
| null | null | null | null |
C01DX07
|
etafenone
| 0.225 |
g
|
O
| null |
B01AE03
|
argatroban
| 0.2 |
g
|
P
| null |
N07XA
|
Gangliosides and ganglioside derivatives
| null | null | null | null |
D07AA02
|
hydrocortisone
| null | null | null | null |
M03BX55
|
thiocolchicoside, combinations
| null | null | null | null |
N06AF06
|
iproclozide
| null | null | null | null |
H02AB05
|
paramethasone
| 4 |
mg
|
P
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.